Quantib® Brain
Quantib
Product specifications |
Information source:
Vendor
Last updated: May 31, 2021 |
General | |
---|---|
Product name | Quantib® Brain |
Company | Quantib |
Subspeciality | Neuro |
Modality | MR |
Disease targeted | Neurodegenerative diseases, multiple sclerosis |
Key-features | White matter, grey matter, ICV and CSF segmentation and quantification, white matter hyperintensity segmentation and quantification |
Suggested use | During: interactive decision support (shows abnormalities/results only on demand), report suggestion |
Data characteristics | |
Population | All with suspicion of neurodegenerative diseases, MS |
Input | |
Input format | DICOM |
Output | segmentation overlay, table of quantified volumes, draft radiology report |
Output format | DICOM |
Technology | |
Integration | Integration with GE Healthcare Advantage Workstation |
Deployment | Locally on dedicated hardware |
Trigger for analysis | Automatically, right after the image acquisition, On demand, triggered by a user through e.g. a button click, image upload, etc. |
Processing time | > 10 minutes |
Certification | |
CE
|
Certified,
Class IIa
, MDR
|
FDA
|
510(k) cleared, Class II |
Market presence | |
On market since | 06-2016 |
Distribution channels | GE Healthcare |
Countries present (clinical, non-research use) | |
Paying clinical customers (institutes) | >100 |
Research/test users (institutes) | |
Pricing | |
Pricing model | Subscription |
Based on | Number of installations |
Evidence | |
Peer reviewed papers on performance | |
Non-peer reviewed papers on performance | |
Other relevant papers |